New Grant Glues Together Research Experts to Tackle Incurable Diseases
An international grant to Thomas Kodadek, Ph.D., will advance his lab’s work on molecular glue degraders for incurable diseases.
Posts tagged as
Diabetes
HiPerGator Supercomputer Accelerates Diabetes Drug Discovery
Compounds able to reprogram insulin-resistant cells into a healthier state, with reduced side effects, are described in a new paper from Griffin lab.
Fellowships: Tony Kuo
Wertheim Fellow, “Tony” Kuang-Ting Kuo, is in the final year of his Ph.D. program in the lab of Scientific Director Patrick Griffin, Ph.D. He recently co-mentored high school student intern Shivangi Saxena. In 2022, Dr. Herbert Wertheim made a transformational $100 million gift to The Herbert Wertheim UF Scripps Institute…
Once-Promising Diabetes Drugs’ Side-Effects Can be Limited, Study Finds
Altering the activity of the PPARg receptor could limit the side-effects of a useful group of diabetes drugs, TZDs.
